After months of discussion, Germany’s Merck KGaA said Monday it would buy SpringWorks Therapeutics for $47 a share in cash, a ...

We are navigating political interference, institutional instability, and growing uncertainty across the cancer research ...

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

It is sad to see pets die of something easily preventable. It's even worse knowing that the owner was misinformed or misled ...

You’re reading the web edition of AACR in 30 Seconds, STAT’s guide to the American Association for Cancer Research annual ...

HHS Robert F. Kennedy Jr. has railed against a “revolving door” between drug companies and the FDA. But HHS' actions now seem ...

Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this ...

Sutter Health has agreed to pay about $230 million to settle a federal class-action lawsuit accusing it of anticompetitive ...

Health Secretary Robert F. Kennedy Jr. spoke at a large meeting of addiction experts, encountering both cheers and repeated ...

The NIH has scaled back its awards of new grants by at least $2.3 billion since the beginning of the year, a STAT analysis ...

STAT is tracking, day by day, what's happened in the words of science and health during the first months of the Trump ...

Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug ...